Structure-related pharmacokinetics of xanthines after direct administration into the peritoneal cavity of rats

Takafumi Kuzuya, Takaaki Hasegawa, Rika Shiraki, Toshitaka Nabeshima

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The pharmacokinetic characteristics, peritoneal permeability and hydrophobicity of three xanthine derivatives, theophylline, enprofylline and 1-methyl-3-propylxanthine (MPX), were investigated in rats. Isotonic saline (30 ml) containing xanthine (2.5, 5 and 10 mg/kg) and blue dextran (0.2%) was administered intraperitoneally. The pharmacokinetic parameters of these xanthines were estimated using concentration-time data obtained from the peritoneal cavity and systemic circulation. Disappearance of these xanthines from the peritoneum declined in almost a monoexponential manner regardless of the dose administered. The volume of distribution (33.9 ml) in the peritoneal cavity was similar to the injection volume, indicating that dialysate was not diluted by the fluid in the peritoneal cavity and the effect of drug adsorption on the peritoneal membrane was minimal. The pharmacokinetics of MPX was dose-dependent, but that of theophylline and enprofylline was not. The fraction of the administered dose absorbed through the peritoneal cavity was 0.71, 0.85, 0.93 for theophylline, enprofylline and MPX, respectively. The peritoneal clearance was significantly different (p < 0.05) among the three xanthines by two-way analysis of variance, and a strong correlation was noted between their peritoneal clearance and hydrophobicity (r = 0.98, p < 0.01). These findings suggest that hydrophobicity is an important determinant in the peritoneal permeation of these xanthines.

Original languageEnglish
Pages (from-to)1051-1055
Number of pages5
JournalBiological and Pharmaceutical Bulletin
Volume20
Issue number10
DOIs
Publication statusPublished - 01-01-1997
Externally publishedYes

Fingerprint

Xanthines
Peritoneal Cavity
Theophylline
Pharmacokinetics
Hydrophobic and Hydrophilic Interactions
Xanthine
Peritoneum
Dialysis Solutions
Adsorption
Permeability
Analysis of Variance
Injections
Membranes
Pharmaceutical Preparations
enprofylline
1-methyl-3-propylxanthine

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science

Cite this

@article{6bd304b03b8b43a99e801e6d0b5ae493,
title = "Structure-related pharmacokinetics of xanthines after direct administration into the peritoneal cavity of rats",
abstract = "The pharmacokinetic characteristics, peritoneal permeability and hydrophobicity of three xanthine derivatives, theophylline, enprofylline and 1-methyl-3-propylxanthine (MPX), were investigated in rats. Isotonic saline (30 ml) containing xanthine (2.5, 5 and 10 mg/kg) and blue dextran (0.2{\%}) was administered intraperitoneally. The pharmacokinetic parameters of these xanthines were estimated using concentration-time data obtained from the peritoneal cavity and systemic circulation. Disappearance of these xanthines from the peritoneum declined in almost a monoexponential manner regardless of the dose administered. The volume of distribution (33.9 ml) in the peritoneal cavity was similar to the injection volume, indicating that dialysate was not diluted by the fluid in the peritoneal cavity and the effect of drug adsorption on the peritoneal membrane was minimal. The pharmacokinetics of MPX was dose-dependent, but that of theophylline and enprofylline was not. The fraction of the administered dose absorbed through the peritoneal cavity was 0.71, 0.85, 0.93 for theophylline, enprofylline and MPX, respectively. The peritoneal clearance was significantly different (p < 0.05) among the three xanthines by two-way analysis of variance, and a strong correlation was noted between their peritoneal clearance and hydrophobicity (r = 0.98, p < 0.01). These findings suggest that hydrophobicity is an important determinant in the peritoneal permeation of these xanthines.",
author = "Takafumi Kuzuya and Takaaki Hasegawa and Rika Shiraki and Toshitaka Nabeshima",
year = "1997",
month = "1",
day = "1",
doi = "10.1248/bpb.20.1051",
language = "English",
volume = "20",
pages = "1051--1055",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "10",

}

Structure-related pharmacokinetics of xanthines after direct administration into the peritoneal cavity of rats. / Kuzuya, Takafumi; Hasegawa, Takaaki; Shiraki, Rika; Nabeshima, Toshitaka.

In: Biological and Pharmaceutical Bulletin, Vol. 20, No. 10, 01.01.1997, p. 1051-1055.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Structure-related pharmacokinetics of xanthines after direct administration into the peritoneal cavity of rats

AU - Kuzuya, Takafumi

AU - Hasegawa, Takaaki

AU - Shiraki, Rika

AU - Nabeshima, Toshitaka

PY - 1997/1/1

Y1 - 1997/1/1

N2 - The pharmacokinetic characteristics, peritoneal permeability and hydrophobicity of three xanthine derivatives, theophylline, enprofylline and 1-methyl-3-propylxanthine (MPX), were investigated in rats. Isotonic saline (30 ml) containing xanthine (2.5, 5 and 10 mg/kg) and blue dextran (0.2%) was administered intraperitoneally. The pharmacokinetic parameters of these xanthines were estimated using concentration-time data obtained from the peritoneal cavity and systemic circulation. Disappearance of these xanthines from the peritoneum declined in almost a monoexponential manner regardless of the dose administered. The volume of distribution (33.9 ml) in the peritoneal cavity was similar to the injection volume, indicating that dialysate was not diluted by the fluid in the peritoneal cavity and the effect of drug adsorption on the peritoneal membrane was minimal. The pharmacokinetics of MPX was dose-dependent, but that of theophylline and enprofylline was not. The fraction of the administered dose absorbed through the peritoneal cavity was 0.71, 0.85, 0.93 for theophylline, enprofylline and MPX, respectively. The peritoneal clearance was significantly different (p < 0.05) among the three xanthines by two-way analysis of variance, and a strong correlation was noted between their peritoneal clearance and hydrophobicity (r = 0.98, p < 0.01). These findings suggest that hydrophobicity is an important determinant in the peritoneal permeation of these xanthines.

AB - The pharmacokinetic characteristics, peritoneal permeability and hydrophobicity of three xanthine derivatives, theophylline, enprofylline and 1-methyl-3-propylxanthine (MPX), were investigated in rats. Isotonic saline (30 ml) containing xanthine (2.5, 5 and 10 mg/kg) and blue dextran (0.2%) was administered intraperitoneally. The pharmacokinetic parameters of these xanthines were estimated using concentration-time data obtained from the peritoneal cavity and systemic circulation. Disappearance of these xanthines from the peritoneum declined in almost a monoexponential manner regardless of the dose administered. The volume of distribution (33.9 ml) in the peritoneal cavity was similar to the injection volume, indicating that dialysate was not diluted by the fluid in the peritoneal cavity and the effect of drug adsorption on the peritoneal membrane was minimal. The pharmacokinetics of MPX was dose-dependent, but that of theophylline and enprofylline was not. The fraction of the administered dose absorbed through the peritoneal cavity was 0.71, 0.85, 0.93 for theophylline, enprofylline and MPX, respectively. The peritoneal clearance was significantly different (p < 0.05) among the three xanthines by two-way analysis of variance, and a strong correlation was noted between their peritoneal clearance and hydrophobicity (r = 0.98, p < 0.01). These findings suggest that hydrophobicity is an important determinant in the peritoneal permeation of these xanthines.

UR - http://www.scopus.com/inward/record.url?scp=0030710522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030710522&partnerID=8YFLogxK

U2 - 10.1248/bpb.20.1051

DO - 10.1248/bpb.20.1051

M3 - Article

VL - 20

SP - 1051

EP - 1055

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 10

ER -